title: MMN responsivity to manipulations of frequency and duration deviants in chronic, clozapine-treated schizophrenia patients.
abstract: Event-related potential (ERP) probing of abnormal sensory processes in schizophrenia with the mismatch negativity (MMN) has shown impairments in auditory change detection, but knowledge of the acoustic features leading to this deficit is incomplete. Changes in the duration and frequency properties of sound stimuli result in diminished MMNs in schizophrenia but it is unclear as to whether this reduced responsiveness is seen with more subtle changes in sound frequency. In a sample of 19 healthy controls and 21 patients with chronic schizophrenia treated with clozapine, MMN was assessed in response to tone frequency changes of 5%, 10% and 20%, and to tone duration changes. Patients exhibited reduced amplitudes and shorter latencies than controls to all frequency changes, and attenuated amplitudes to tone duration increments and decrements. Clozapine dose was related to MMN, with increasing dose being positively associated with frequency-MMN amplitudes (10% ∆f, 20% ∆f) and negatively associated with the amplitude and latency of duration-MMNs. These data support the well-established findings of auditory sensory abnormality in schizophrenia and underscore the sensitivity of MMN to relatively small auditory change detection deficits that may appear to characterize chronic schizophrenia.
authors.affiliation: Geriatrics/Integrated Forensic Program, Royal Ottawa Mental Health Centre, Ottawa, ON, Canada K1Z 7K4.
authors.forename: Jemeen
authors.initials: J
authors.lastname: Horton
authors.forename: Anne
authors.initials: A
authors.lastname: Millar
authors.forename: Alain
authors.initials: A
authors.lastname: Labelle
authors.forename: Verner J
authors.initials: VJ
authors.lastname: Knott
mesh_terms: D000161:Acoustic Stimulation / Q000379:methods; D000328:Adult; D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000494:pharmacology*; D003024:Clozapine / Q000008:administration & dosage / Q000494:pharmacology*; D003265:Contingent Negative Variation / Q000187:drug effects* / Q000502:physiology; D004569:Electroencephalography / Q000379:methods; D005072:Evoked Potentials, Auditory / Q000187:drug effects; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D015999:Multivariate Analysis; D011569:Psychiatric Status Rating Scales; D011571:Psychoacoustics; D011930:Reaction Time / Q000187:drug effects; D012559:Schizophrenia / Q000188:drug therapy / Q000503:physiopathology*
chemical_list: D014150:Antipsychotic Agents; D003024:Clozapine